Abstract:Objective To compare the perioperative clinical outcomes of vacuum-assisted breast biopsy (VABB) and conventional open excision for benign breast tumors.Methods A retrospective analysis was conducted on 222 patients with benign breast tumors treated at Ma'anshan People's Hospital from January 2022 to January 2025. Based on surgical approach, patients were divided into an observation group (n = 122, VABB) and a control group (n = 100, open excision). Perioperative parameters, wound characteristics, recovery outcomes, cosmetic results, inflammatory stress markers, pain levels, and postoperative complications were compared between the two groups.Results The observation group had a shorter operative duration and less intraoperative blood loss than the control group (P < 0.05). Incision length, wound healing time, and postoperative length of hospital stay were all shorter in the observation group (P < 0.05). No significant difference was found in the rate of residual tumor between the two groups (P >0.05). The scores for vascular distribution, pigmentation, thickness, and softness were all lower in the observation group (P < 0.05). Postoperative PCT, CRP, NE, and Cor levels were lower in the observation group compared with the control group (P < 0.05), and their differences before and after surgery were also smaller in the observation group (P < 0 .05). The NRS scores at postoperative days 1, 3, and 5 under resting conditions were compared between the two groups using repeated-measures analysis of variance. The results demonstrated that NRS scores differed significantly across different time points (P < 0.05), and that there was a significant difference in NRS scores between the two groups (P < 0.05), with the observation group showing lower scores and better analgesic effects. The change trends of NRS scores over time also differed significantly between the two groups (P < 0.05). The incidence of postoperative complications was lower in the observation group (P < 0.05).Conclusion VABB provides comparable tumor resection efficacy while offering the advantages of minimal trauma, faster recovery, better cosmetic results, and fewer complications. It represents an optimal minimally invasive surgical option for patients with benign breast tumors.